Market Overview

The Duvelisib Capsule market is predicted to develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it is projected to reach USD xx Billion, based on an average growth pattern. The market is estimated to reach a value of USD xx Billion in 2024.

SOURCE: We Market Research

Oral duvelisib, brand name Copiktra, is prescribed to individuals with follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) who have not responded to previous treatments. It functions by preventing the growth and survival of cancer cells by blocking the PI3K-delta and PI3K-gamma enzymes. This interference aids in limiting the growth of malignant cells. A healthcare professional determines the appropriate dosage for Duvelisib, which is taken as a capsule. Although more severe adverse effects are possible, common side effects include fatigue, nausea, and diarrhea. Usually, doctors prescribe it when no other course of treatment works.

The market for duvelisib capsules is propelled by the increasing prevalence of diseases such as follicular lymphoma and chronic lymphocytic leukemia, developments in oncology, and growing medication indications. Better access to and reimbursement for healthcare, enhanced diagnostic methods, and higher awareness of cancer are all factors. Duvelisib's market share is further increased by its distinct safety and efficacy profile, as well as by the positive attitudes of doctors and patients. Increasing market penetration requires effective marketing and distribution methods. In the market for cancer medications, these elements combined are what propel demand and growth for duvelisib.

Market Scope

Duvelisib Capsule Industry: Dynamics & Restrains

Market opportunity:

 

We Market Research: Duvelisib Capsule Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Duvelisib Capsule Segmentation

Market- By Application Analysis

By Application, the Duvelisib Capsule Market is Categories into Chronic lymphocytic leukemia (CLL) and Others. The Acute Myeloid Leukemia (AML) segment accounts for the largest share of around 89% in 2024.

Chronic lymphocytic leukemia (CLL) includes rising CLL incidence, advancements in targeted therapies, increasing healthcare awareness, and growing demand for effective, innovative treatments addressing unmet medical needs.

The following segments are part of an in-depth analysis of the global Duvelisib Capsule market:

Duvelisib Capsule Industry: Regional Analysis

North America Market Forecast

North America dominates the Duvelisib Capsule Market with the highest revenue generating market with share of more than 47%. The North American market is driven by high cancer prevalence, with a significant number of patients requiring targeted therapies like Duvelisib. The region benefits from advanced healthcare infrastructure, high spending on healthcare, and substantial investments in research and development. FDA approvals also play a crucial role in market expansion, ensuring that innovative treatments are accessible to patients and integrated into clinical practice.

Europe Market Statistics

In Europe, the market is fueled by a high incidence of cancers and a strong presence of major pharmaceutical companies and research institutions. The emphasis on personalized medicine and increasing adoption of targeted therapies contribute to market growth. The European Medicines Agency (EMA) oversees drug approvals and regulations, which helps ensure that effective treatments like Duvelisib are available across diverse European countries.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Duvelisib Capsule market during the forecast period. The Asia-Pacific market is expanding due to a rising incidence of cancer and improvements in healthcare infrastructure across the region. Increased awareness of targeted therapies and growing healthcare access drive market growth, particularly in emerging economies like China and India. Investment in biotechnology and advancements in medical technology further support the market's development, creating opportunities for innovative treatments.

Key Market Players

·         CSPC

·         Secura Bio                                                                                                                                                                                                                  

1.      Global Duvelisib Capsule Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Duvelisib Capsule Market Scope and Market Estimation

1.2.1. Global Duvelisib Capsule Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Duvelisib Capsule Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Application of Global Duvelisib Capsule Market

1.3.2. Distribution Channel of Global Duvelisib Capsule Market

1.3.3. Region of Global Duvelisib Capsule Market

2.      Executive Summary

2.1.    Market Dynamics

2.1.1. Drivers

2.1.2. Limitations

2.1.3. Opportunities

2.1.4. Impact Analysis of Drivers and Restraints

2.2.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.3.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.4.    Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitutes

2.4.4. Threat of New Entrants

2.4.5. Competitive Rivalry

2.5.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Duvelisib Capsule Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Duvelisib Capsule Market Estimates & Forecast Trend Analysis, by Application

4.1.    Global Duvelisib Capsule Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

4.1.1. Chronic lymphocytic leukemia (CLL)

4.1.2. Others

5.      Global Duvelisib Capsule Market Estimates & Forecast Trend Analysis, by Distribution Channel

5.1.    Global Duvelisib Capsule Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

5.1.1. Retail Pharmacies

5.1.2. Hospital Pharmacies

5.1.3. Online Pharmacies

6.      Global Duvelisib Capsule Market Estimates & Forecast Trend Analysis, by region

6.1.    Global Duvelisib Capsule Market Revenue (US$ Mn) Estimates and Forecasts, by region, 2019 to 2034

6.1.1. North America

6.1.2. Europe

6.1.3. Asia Pacific

6.1.4. Middle East & Africa

6.1.5. South America

7.      North America Duvelisib Capsule Market: Estimates & Forecast Trend Analysis

7.1.    North America Duvelisib Capsule Market Assessments & Key Findings

7.1.1. North America Duvelisib Capsule Market Introduction

7.1.2. North America Duvelisib Capsule Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

7.1.2.1.   By Application

7.1.2.2.   By Distribution Channel

7.1.2.3.   By Country

7.1.2.3.1.     The U.S.

7.1.2.3.2.     Canada

7.1.2.3.3.     Mexico

8.      Europe Duvelisib Capsule Market: Estimates & Forecast Trend Analysis

8.1.    Europe Duvelisib Capsule Market Assessments & Key Findings

8.1.1. Europe Duvelisib Capsule Market Introduction

8.1.2. Europe Duvelisib Capsule Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

8.1.2.1.   By Application

8.1.2.2.   By Distribution Channel

8.1.2.3.        By Country

8.1.2.3.1.     Germany

8.1.2.3.2.     U.K.

8.1.2.3.3.     France

8.1.2.3.4.     Italy

8.1.2.3.5.     Spain

8.1.2.3.6.     Russia

8.1.2.3.7.     Rest of Europe

9.      Asia Pacific Duvelisib Capsule Market: Estimates & Forecast Trend Analysis

9.1.    Asia Pacific Market Assessments & Key Findings

9.1.1. Asia Pacific Duvelisib Capsule Market Introduction

9.1.2. Asia Pacific Duvelisib Capsule Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By Application

9.1.2.2.   By Distribution Channel

9.1.2.3.        By Country

9.1.2.3.1.     China

9.1.2.3.2.     Japan

9.1.2.3.3.     India

9.1.2.3.4.     Australia

9.1.2.3.5.     South Korea

9.1.2.3.6.     ASEAN

9.1.2.3.7.     Rest of Asia Pacific

10.  Middle East & Africa Duvelisib Capsule Market: Estimates & Forecast Trend Analysis

10.1.  Middle East & Africa Market Assessments & Key Findings

10.1.1.   Middle East & Africa Duvelisib Capsule Market Introduction

10.1.2.   Middle East & Africa Duvelisib Capsule Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By Application

10.1.2.2.    By Distribution Channel

10.1.2.3.    By Country

10.1.2.3.1. U.A.E.

10.1.2.3.2. Saudi Arabia

10.1.2.3.3. Egypt

10.1.2.3.4. South Africa

10.1.2.3.5. Rest of Middle East & Africa

11.  South America Duvelisib Capsule Market: Estimates & Forecast Trend Analysis

11.1.  South America Market Assessments & Key Findings

11.1.1.   South America Duvelisib Capsule Market Introduction

11.1.2.   South America Duvelisib Capsule Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By Application

11.1.2.2.    By Distribution Channel

11.1.2.3.    By Country

11.1.2.3.1. Brazil

11.1.2.3.2. Argentina

11.1.2.3.3. Colombia

11.1.2.3.4. Rest of South America

12.  Competition Landscape

12.1.  Global Duvelisib Capsule Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

12.2.  Global Duvelisib Capsule Market Competition White Space Analysis, By End-user

12.3.  Global Duvelisib Capsule Market Competition Heat Map Analysis, By End-user

12.4.  Global Duvelisib Capsule Market Concentration & Company Market Shares (%) Analysis, 2022

13.  Company Profiles

13.1.                     CSPC

13.1.1.   Company Overview & Key Stats

13.1.2.   Financial Performance & KPIs

13.1.3.   Product Portfolio

13.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

13.2.      Secura Bio

13.3.      Others

14.  Research Methodology

14.1.  External Transportations / Databases

14.2.  Internal Proprietary Database

14.3.  Primary Research

14.4.  Secondary Research

14.5.  Assumptions

14.6.  Limitations

14.7.  Report FAQs

15.  Research Findings & Conclusion